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Background: Iodinated contrast during endovascular aneurysm repair (EVAR) is used with caution in patients with
chronic kidney disease. Contrast-enhanced ultrasound (CEUS) imaging using nonnephrotoxic sulphur hexaﬂuoride
microbubble contrast is a novel imaging modality that accurately identiﬁes and characterizes endoleaks during EVAR
follow-up. We report our initial experience of using three-dimensional (3D) CEUS imaging intraoperatively as
completion imaging after endograft deployment. Our aim was to compare intraoperative 3D CEUS against uniplanar
angiography in the detection of endoleak, stent deformity, and renal artery perfusion during EVAR.
Methods: The study enrolled 20 patients undergoing elective conventional infrarenal EVAR, after which a completion
angiogram was performed and the presence of endoleak, renal artery perfusion, or device deformity were recorded. With
the patient still under anesthetic, a vascular scientist blinded to angiographic ﬁndings performed 3D CEUS and reported
on the same parameters.
Results: Three endoleaks, one type I and two type II, were detected on uniplanar angiography and 13 endoleaks, 11 type
II and two type I, were found using 3D CEUS imaging. Of note, one of these type I endoleaks was not seen on angi-
ography, and this patient underwent balloon moulding of the neck with resolution of the endoleak on repeat imaging. Of
the 11 type II endoleaks seen with 3D CEUS imaging, the inﬂow vessel was identiﬁed in nine cases. No graft deformity or
limb kinking was seen in any patient. Both renal arteries could be visualized in 10 patients, whereas the target renal artery
was seen in 11 patients. In the remaining patients, the renal arteries could not be visualized, mainly due to intra-
abdominal gas or patient body habitus.
Conclusions: 3D CEUS imaging detected endoleaks not seen on uniplanar digital subtraction angiography, including a
clinically important type I endoleak, and was also more sensitive than 2D CEUS imaging for the detection of the source of
endoleak. This technology has the potential to supplement or replace digital subtraction angiography for completion im-
aging to reduce the use of x-ray contrast. Intraoperative 3DCEUS has been applied to allow safe EVARwith ultralow or no
iodinated contrast usage in selected cases, without compromising completion imaging. (J Vasc Surg 2014;60:1468-72.)Endovascular aneurysm repair (EVAR) has reduced the
incidence of postoperative mortality compared with open
repair,1 although EVAR may be complicated by acute kid-
ney injury due to maldeployment, renal microemboliza-
tion, or the use of iodinated contrast (IC) media. IC can
result in short-term and long-term contrast-induced ne-
phropathy, particularly in patients with underlying chronic
kidney disease (CKD), and is contraindicated in those who
are allergic to iodine.2,3
Standard endograft deployment technique uses digital
subtraction angiography (DSA) with IC media to aid intra-
arterial navigation and to provide quality-assurance comple-
tion imaging to examine for the presence of endoleaks,the Department of Vascular Surgerya and Independent Vascular Serv-
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8visceral vessel patency, and endograft integrity. Although
an essential element of safe endograft deployment, comple-
tion imaging signiﬁcantly contributes to the total IC load,
especially if several angiographic runs are required. Carbon
dioxide (CO2) has been used as a non-nephrotoxic alterna-
tive to IC,4 but its utility is limited to endograft deployment
because CO2 does not provide adequate image quality for
completion quality control.5
The role of contrast-enhanced ultrasound (CEUS) im-
aging in the context of post-EVAR surveillance has gained
acceptability in recent years6-9 because it presents a cost-
effective alternative to computed tomography (CT) that
does not necessitate nephrotoxic IC or ionizing radiation.
CEUS imaging uses non-nephrotoxic sulphur hexaﬂuoride
microbubbles as contrast, which are completely eliminated
through the lungs. Three-dimensional (3D) CEUS is an
evolution of this technology that uses positional informa-
tion from magnetic ﬁeld emitters to place and orientate
the ultrasound transducer probe precisely in space to allow
dynamic interrogation of an endograft from any angle
within the aneurysm. A pilot study from our institution
showed that 3D CEUS has accuracy comparable to or
better than CT to detect endoleaks during post-EVAR
follow-up.10
Table I. Patient demographics
Age, years Sex BMI, kg/m2
Aneurysm
size, cm
Current
smoker Diabetes
SBP,
mm Hg
DBP,
mm Hg
Creatinine,
mmol/L
EVAR
device
70 M 33.6 7.2 No No 128 79 175 Cook LPa
86 M 27.8 6 No No 160 80 109 Endurant IIb
74 M 26.1 7.8 No No 171 74 118 Zenitha
72 M 30.5 5.6 No No 130 90 115 Endurant IIb
77 M 25.2 6.1 Yes No 161 95 213 Ovationc
66 M 32.7 5.5 No No 124 83 71 Endurant II
75 M 30.4 5.7 No No 127 72 120 Endurant II
68 M 23.1 8.4 No No 150 70 83 Endurant II
79 M 29.8 6.4 No No 193 93 102 Ovation
79 M 24.0 5.7 No No 142 65 59 Endurant II
64 M 30.0 6.7 No No 151 80 66 Aorﬁxd
86 F 26.4 5.5 No No 131 63 83 Ovation
84 M 30.1 5.5 No No 118 68 84 Endurant II
88 F 28.3 5.8 No Yes 110 40 72 Endurant II
74 M 32.2 7.1 No No 137 68 83 Endurant II
81 M 20.0 4.2 (iliac) Yes Yes 128 64 66 Endurant II
72 M 26.0 5.3 No No 162 80 129 Endurant II
83 M 27.2 5.7 No No 165 74 69 Endurant II
86 M 29.0 6.1 No No 128 61 102 Anacondae
75 M 29.0 9.5 No No 142 48 107 Endurant II
BMI, Body mass index; DBP, diastolic blood pressure; F, female; M, male; SBP, systolic blood pressure.
aCook, Bloomington, Ind.
bMedtronic, Minneapolis, Minn.
cTriVascular, Santa Rosa, Calif.
dLombard Medical Technologies PLC, Oxfordshire, UK.
eSulzer Vascutech, Bad Soden, Germany.
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tial to visualize stent graft positioning and endoleak imme-
diately after deployment while reducing the overall
requirement of IC media. Thus, intraoperative CEUS
potentially has clinical utility in patients with chronic renal
impairment or when CO2 is used the primary contrast me-
dium. The aim of this feasibility study was to assess the clin-
ical utility of 3D CEUS for intraoperative completion
imaging after EVAR as an alternative to conventional uni-
planar catheter angiography for the detection of endoleak,
endograft deformity, and renal artery patency.METHODS
The study prospectively enrolled 20 patients undergo-
ing elective infrarenal EVAR under the care of a single sur-
geon. The local ethics committee approved the project, and
the patients gave informed consent. All patients were
initially seen in the clinic and reviewed by a consultant
vascular surgeon. Suitability for EVAR was determined
from an initial CT scan using IC. The morphologic charac-
teristics of the aneurysm and access vessels were reviewed at
a multidisciplinary team meeting.
All patients underwent EVAR deployment while under
general anesthesia in a vascular operating theater with mo-
bile C-arm imaging. After endograft deployment, a standard
completion uniplanar DSA was done using 20 mL full-
strength iodixanol contrast (Visipaque 270; GEHealthcare,
Hertfordshire, UK) injected at 10 to 15 mL/s. The pres-
ence of endoleak, renal artery perfusion, and devicedeformity were recorded. Endoleaks were characterized by
type and source. Renal artery perfusion and presence of graft
deformity were also noted. With the patient still anesthe-
tized, an accredited vascular scientist with speciﬁc training
in 3D CEUS attended the theater. This individual, who
was blinded to the angiographic ﬁndings, performed con-
ventional 2D and 3D CEUS imaging to measure the same
parameters.
The 3D CEUS was undertaken with a Phillips IU22 ul-
trasound console (Phillips, Amsterdam, Netherlands) using
a C5 2-MHz curved array probe. Then, 1-mL boluses of
sodium hexaﬂuoride (SonoVue, Bracco, Italy) were admin-
istered intravenously to a maximum of 5 mL. The images
acquired were processed using a Curefab CS 3D system
(Curefab, Munich, Germany) and were replayed and
manipulated to identify endoleaks. The 3D CEUS ﬁndings
were then verbally relayed to the team performing the
EVAR and recorded. If necessary, any interventions based
on the 3D CEUS ﬁndings were then undertaken.
The recorded outcome measures were presence of an
endoleak, type of endoleak, inﬂow vessel of endoleak, renal
artery visualization and patency, and evidence of limb
kinking.RESULTS
The study included 20 consenting patients, and their
demographics are given in Table I. Of these patients, 19 un-
derwent EVAR for infrarenal abdominal aortic aneurysm,
including 18 bifurcated stent grafts and one aortouniiliac
Fig. A type I endoleak (arrow) as seen on the Curefab CS system workstation (Curefab, Munich, Germany) that was
not identiﬁed on uniplanar angiography.
Table II. Endoleak detection by imaging modality used
Endoleak
type
Imaging modality
Uniplanar DSA, No. 2D CEUS, No. 3D CEUS, No.
I 1 3 2
II 2 9 11
III 0 1 0
Total 3 13 13
2D, Two-dimensional; 3D, three-dimensional; CEUS, contrast-enhanced
ultrasound; DSA, digital subtraction angiography.
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common iliac aneurysm that could not be treated with a
straight stent graft. The choice of stent graft was determined
by aneurysm anatomy and was within the manufacturer’s in-
structions for use in all cases.
Three endoleaksdone type I and two type IIdwere
detected on uniplanar angiography. 2D CEUS imaging
found 13 endoleaks: 3 type I, 9 type II, and 1 type III.
3D CEUS also demonstrated 13 endoleaks, including
both type I endoleaks. Of note, one of these type I endo-
leaks was not seen on angiography (Fig), and this patient
underwent balloon molding of the neck, with resolution
of the endoleak on repeat 3D CEUS imaging. Of the 11
type II endoleaks seen with 3D CEUS imaging, the inﬂow
vessel was identiﬁed in nine. 3D CEUS imaging reclassiﬁed
two endoleaks described by 2D CEUS; the type III endo-
leak was found to be a type II and one type I was found to
be a type II. Table II summarizes endoleak detection and
classiﬁcation.
No graft deformity or limb kinking was seen in any pa-
tient. Both renal arteries could be visualized in 10 patients,
whereas the largest (lowest) renal artery was seen in 11 pa-
tients. The renal arteries in the remaining patients could
not be visualized due to intra-abdominal gas and patient
body habitus. Use of the microbubble contrast did not
cause any adverse reactions or complications.
DISCUSSION
Standard uniplanar DSA using IC has been found to
miss 4% to 9% of endoleaks.11,12 This may be mitigated
by multiplanar or rotational angiography but at the expenseof increased intra-arterial contrast volume and radiation
exposure. A retrospective analysis of 615 EVARs found
that duplex scanning #48 hours of surgery found endo-
leaks in 53 patients, including 17 type I and eight type
III endoleaks, of which 10 of the type I leaks and none
of the type III leaks were seen on completion uniplanar
angiography.12
The Curefab CS system represents an enhancement to
standard duplex ultrasound technology by combining
contrast-enhanced duplex, a magnetic ﬁeld emitter, and
tracking sensors that can be applied to most standard ultra-
sound probes. Processing produces a 3D image that can be
enlarged and rotated so the aneurysm body and the graft
can be identiﬁed from all angles. The ability to rotate the
3D reconstruction and scroll through the ultrasound image
slice-by-slice, akin to CT images, simultaneously in sagittal,
coronal, and transverse planes, allows the operator to
ensure that adjacent vessels are not mistaken for endoleaks.
An additional beneﬁt of enabling imaging in three planes
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 6 Ormesher et al 1471simultaneously, without manually rotating the transducer,
is that the operator does not lose a small area of interest
during manual rotation, thus allowing conﬁdent identiﬁca-
tion of even small leaks.
Because images are acquired in the same way as conven-
tional CEUS, 3D CEUS imaging does not add to the time
required for scanning and is completed inw5 minutes. Im-
aging processing takes seconds, and the time for interpreta-
tion depends on the presence or absence of an endoleak. In
our experience, the scanning, interpretation, and communi-
cation of results added only 10 minutes to the EVAR proce-
dure. Provided the operator has experience with CEUS, we
have found 3D CEUS images are easier to interpret due to
the ability to manipulate the images and view them in mul-
tiple planes. A pilot study from our institution showed
promising results using 3D CEUS for endoleak detection
compared with CT as a gold standard, with encouraging
inter-rater reliability (k ¼ 0.88; 95% conﬁdence interval,
0.718-1.0).10
In this series, 3DCEUS imaging detected a type I endo-
leak that was not seen on angiography. This was treated at
the same sitting with balloon molding. We noted that 2D
CEUS imaging found the same number of endoleaks as
3DCEUS imaging, although 3Dwas superior in delineating
the inﬂow vessel and also reclassiﬁed two clinically signiﬁ-
cant endoleaksdone type III and one type Iadto type II
leaks that did not require any immediate treatment. In
each of these cases, the ability to manipulate the 3D images
allowed for a more detailed interrogation of the ultrasound
data and a more accurate diagnosis. Although it is the expe-
rience of endovascular therapists that some type I endoleaks
will seal in the postoperative period after reversal of antico-
agulation, there is currently no way to predict those that will
resolve spontaneously.12,13
The type I leak seen on CEUS imaging and not on
DSA was thought to be signiﬁcant due to the volume of
contrast seen ﬂowing into the sac. We believe that most
endovascular specialists would treat an endoleak of this
type. Although the renal arteries could not be seen in
50% of cases, in our experience of CEUS imaging, this
does not preclude an accurate diagnosis of type I endoleaks
due to their characteristic appearance. We previously estab-
lished that 3D CEUS imaging has high endoleak sensitivity
compared with CT scanning.10 Although the present study
is limited by the number of patients, it provides scope for a
larger-scale study involving a greater number of patients. A
paired analysis of completion 3D CEUS scanning with
biplanar angiography in patients with adequate renal func-
tion would further assess the sensitivity to detect endoleaks.
The results suggest that 3D CEUS imaging is either non-
inferior or superior to uniplanar angiography in endoleak
detection.
The main utility of the addition of a 3D system is the
ease of interpretation and image manipulation that is
afforded by the volumetric and multiplanar reconstruc-
tions. A frequent criticism of US modalities for EVAR sur-
veillance is operator dependency and the difﬁculties of
interpreting 2D images in three dimensions; this may bemitigated by the use of a 3D system. Duplex also affords
advantages of hemodynamic measurements to assess for
limb kinking that may be missed due to parallax on angiog-
raphy, although no limb problems were found in this series.
The main application of 3D CEUS imaging in this
setting is for patients with impaired renal function where
there is a priority to avoid IC volume or in emergency cases
with a background of CKD where an additional acute kid-
ney injury is a concern due to repeated contrast loads from
CT scanning and to hypotension. Intraoperative 2D or
3D CEUS can provide quality control imaging for EVAR
performed using CO2 angiography. CO2 angiography is
an attractive option for arterial navigation and endograft
deployment in patients with poor renal function,4,14
although it is generally inadequate for completion imaging.5
In three cases at our institution, we used CO2 for nav-
igation and deployment of conventional infrarenal endog-
rafts and 3D CEUS for completion imaging, allowing for
contrast-free or ultralow-contrast EVAR. In the ﬁrst case,
we treated a patient with stage IV CKD with an estimated
glomerular ﬁltration rate (eGFR) of 20 mL/min/1.73 m2
using a bifurcated Endurant II (Medtronic, Minneapolis,
Minn) stent graft. We found that CO2 provided adequate
imaging quality to deﬁne the renal arteries and the iliac
bifurcation. No endoleaks were seen on uniplanar CO2
angiography, and this was conﬁrmed with intraoperative
3D CEUS, which also demonstrated renal artery patency.
The second patient also had stage IV CKD (eGFR,
30 mL/min/1.73 m2) and underwent EVAR using a
bifurcated device. In this case, CO2 failed to adequately
demonstrate the target renal artery before deployment
and therefore we used a hand-injection of 5 mL contrast
to conﬁrm the stent graft position below the renal arteries.
Imaging of the iliac system was clear enough to then allow
graft deployment, and completion imaging was performed
with 3D CEUS.
The third patient presented with a ruptured aortoiliac
aneurysm. Intra-arterial contrast was used to deﬁne the iliac
anatomy and embolize the internal iliac artery; however,
graft deployment was performed with CO2 angiography.
Completion imaging with performed with CEUS and
limited contrast dose to 25 mL. We obtained full comple-
tion imaging in all three patients, and no patient had a
postoperative decline in eGFR.
CONCLUSIONS
The results of this feasibility study suggest that intrao-
perative 3D CEUS imaging accurately identiﬁes and
characterizes endoleaks immediately after stent graft
deployment. Furthermore, 3D CEUS imaging was able
to detect endoleaks not seen on uniplanar DSA, including
clinically important type I endoleaks, and has advantages
over 2D CEUS imaging in inﬂow vessel identiﬁcation
and image manipulation. The lowest renal artery could
be seen reliably in only 50% of patients; however, by adding
CO2 angiography to guide deployment, this technology
has the potential to replace standard completion DSA in
patients where renal function is threatened or when the
JOURNAL OF VASCULAR SURGERY
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tain. Intraoperative 3D CEUS combined with CO2 imag-
ing has been applied to allow safe EVAR with ultralow
IC or no IC usage in selected patients, without compro-
mising completion imaging.
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